Dr RR Baliga's "Got Knowledge Doc" Podkast

⚕️🧠 Long before modern physiology, Erasistratus (c. 304–250 BCE) was asking a revolutionary question: How does the body actually work? Working in Alexandria alongside Herophilus, he helped establish one of history's first great anatomy schools. He described heart valves, distinguished sensory from motor nerves, linked nerves to the brain, and recognized that the heart functions as a pump rather t...

🚀 Major advance in nephrology and cardiorenal medicine!   The INFINITY pooled analysis (14,574 participants) demonstrates that finerenone reduces CKD progression, kidney failure, heart failure hospitalization, cardiovascular death, and even all-cause mortality across a broad spectrum of chronic kidney disease—not just type 2 diabetes. 🩺❤️🩺   Benefits were remarkably consistent across glycemic s...

🧬💤🏃‍♂️ Can lifestyle modify the cardiovascular risk associated with clonal haematopoiesis (CH)?   In this elegant Nature study, investigators demonstrate that sleep and exercise exert mutation-specific effects on CH. Moderate-to-vigorous physical activity was associated with lower prevalence of non-DNMT3A CH in large human cohorts, while mechanistic studies revealed that uninterrupted sleep and...

🔥 Can a gout flare trigger a heart rhythm problem?   A fascinating study from England and Sweden found that patients with gout experienced a significantly higher risk of developing tachyarrhythmias—predominantly atrial fibrillation/flutter—within 30 days of a gout flare, with signals extending up to 60 days in self-controlled analyses. ❤️⚡   The findings reinforce the concept that acute inflamma...

🚑 How much fluid is too much in septic shock?   The ARISE FLUIDS trial tackled one of critical care's most debated questions: should clinicians prioritize early vasopressors with restricted fluids or continue a more liberal fluid strategy?   📊 Among 963 patients with septic shock, early vasopressors reduced fluid exposure by >1 liter and significantly lowered pulmonary edema (0.6% vs 5.0%; P

The new 2026 AHA/ACC/ADA/ASN Cardiovascular–Kidney–Metabolic (CKM) Guideline reframes chronic disease through a unified lens connecting obesity, diabetes, chronic kidney disease, and cardiovascular disease. Key themes: ✅ CKM staging across the life course ✅ PREVENT risk assessment for personalized care ✅ Early detection of kidney and cardiometabolic risk ✅ Lifestyle and weight management as fo...

🫀 The 2026 ACC/AHA Multisociety Guideline on the Management of Dyslipidemia marks a major shift in preventive cardiology. Key updates include universal Lp(a) testing at least once in adulthood, greater emphasis on ApoB, adoption of the PREVENT risk equations, return of LDL-C treatment goals, and more aggressive use of nonstatin therapies to achieve risk-based targets. The message is simple: ident...

⚕️🧠 Before modern anatomy labs, there was Herophilus (335–280 BCE)—the physician often called the Father of Anatomy. Working in Alexandria, he became the first known scientist to systematically dissect human cadavers, transforming medicine from speculation into observation. He distinguished arteries from veins, studied the pulse with a water clock, described the retina and optic nerve, and boldly...

🫀🔥 Is cholesterol the whole story behind heart disease? Increasingly, the answer appears to be no. A fascinating Nature Medicine review explores how cardiovascular inflammation is emerging as a major driver of atherosclerosis, myocardial infarction, stroke, and heart failure. From AI-enhanced coronary CT imaging to novel therapies targeting IL-6, IL-1, NLRP3 inflammasomes, and regulatory T cells...

🫁🔬 Can a simple blood test identify people at risk for lung cancer years before diagnosis?   A remarkable new study in Cell describes a 14-protein plasma signature that predicts lung cancer more than 5 years before clinical detection. The work links air pollution, EGFR-driven tumorigenesis, and IL-1β–mediated inflammation to a shared tumor-promoting state and suggests a path toward molecular can...

🧬 Groundbreaking NEJM report! Two highly sensitized kidney transplant candidates (cPRA ~99.995–99.998%) underwent successful transplantation after dual CD19- and BCMA-targeted CAR-T therapy. 🎯   Rather than simply removing antibodies, investigators targeted the cells that produce them—memory B cells and plasma cells. The result? Profound reduction in anti-HLA antibodies, successful transplantati...

💥 What if an immune cell could defend the body by literally exploding? A fascinating new study in Cell describes "ruptoblasts," a previously unknown cytotoxic cell type in planarian flatworms. Triggered by activin signaling, these cells undergo an explosive form of death called ruptosis, releasing potent diffusible factors that rapidly kill nearby cells and bacteria. 🧬⚡ The work links hormone s...

📱❤️ Can your smartphone become a heart monitor?   A landmark Nature study demonstrates that passive heart-rate monitoring using a smartphone's front-facing camera can accurately measure heart rate and resting heart rate during everyday phone use—without a wearable device. The AI-powered system achieved industry accuracy standards across diverse skin tones and showed strong correlation with cardio...

🍷 How much alcohol is truly safe?   A landmark Burden of Proof study published in Nature Health analyzed 843 cohort and case-control studies examining alcohol and 20 major health outcomes.   Key findings: ✅ Even low levels of alcohol increased the risk of several cancers. ✅ Higher alcohol intake increased risk across all outcomes studied. ✅ Low-to-moderate intake showed possible associations w...

🏮⚕️ More than 2,300 years ago, the legendary Chinese physician Bian Que (Qin Yueren) taught a lesson that remains central to medicine today: detect disease early.   Known for his four-step diagnostic method—Looking 👁️, Listening 👂, Inquiring 💬, and Taking the Pulse ❤️—Bian Que emphasized careful observation and individualized care long before modern diagnostic technology existed.   His famous s...

🧠 Alzheimer's disease remains the leading cause of dementia worldwide, but the field is changing rapidly.   New advances in genetics, blood-based biomarkers, amyloid and tau PET imaging, and disease-modifying therapies are transforming how we diagnose and manage this devastating condition. From APOE genetics to plasma p-tau217 and anti-amyloid treatments, we are entering an era of earlier detecti...

🩺💊 Which blood pressure medications do patients tolerate best?   A major JAMA network meta-analysis of 716 randomized trials involving 159,362 participants found important differences in adverse effects and treatment discontinuation across antihypertensive regimens.   🏆 ARB + CCB combinations ranked as the most tolerated therapy. ✅ ARB-containing regimens consistently performed best. ⚠️ CCBs w...

🧬 Aging leaves a molecular fingerprint—and we can now read it.   A remarkable Nature study analyzed >11,000 transcriptomes across mice, rats, macaques, and humans to identify universal transcriptomic hallmarks of ageing. The investigators developed highly accurate gene-expression clocks that predict biological age, mortality risk, lifespan modulation, and responses to rejuvenation interventions....

🫀 Coronary microvascular dysfunction is no longer a "hidden" diagnosis.   The new FLOW-CMD Registry published in The Lancet demonstrates that coronary microvascular dysfunction frequently coexists with obstructive coronary artery disease and significantly increases adverse cardiovascular outcomes.   Patients with CMD had: ⚠️ Higher cardiac death ⚠️ More repeat revascularization ⚠️ Increased heart...

🫀 Fascinating new study in the The New England Journal of Medicine explores "Stem-Cell–Derived Biologic Ventricular Assist Tissue (BioVAT)" for advanced heart failure. Investigators demonstrated that engineered heart-muscle patches derived from induced pluripotent stem cells increased ventricular wall thickness, modestly improved left ventricular ejection fraction, and enhanced quality of life in...

🧬 Could a single infusion replace decades of lipid-lowering therapy?   The new NEJM study on VERVE-102 explores in vivo base editing of PCSK9 using CRISPR-inspired adenine base editing technology. In this phase 1 trial, a one-time infusion produced LDL cholesterol reductions up to 62% with durable effects extending beyond 1 year. ❤️   This may represent a major shift from chronic pharmacotherapy...

⚕️ Long before modern preventive medicine, Diocles of Carystus emphasized something remarkably familiar today: hygiene, exercise, balanced diet, sleep, and daily discipline. A physician of 4th century BCE Greece, Diocles helped advance anatomy, surgery, nutrition, and holistic health. Some ancient sources even credit him with being among the first to use the term "anatomy." 🧠 His philosophy was s...

⚖️🚀 RETATRUTIDE may redefine obesity medicine.   In the Phase 3 TRIUMPH-1 trial, Lilly's triple agonist (GIP/GLP-1/glucagon) achieved an astonishing 28.3% average weight loss at 80 weeks, with some patients exceeding 30% weight reduction — territory once associated mainly with bariatric surgery. 📉   Even the 4 mg dose achieved nearly 20% weight loss with fewer discontinuations. Significant impro...

🧪 New in JAMA: 4% tetrasodium EDTA significantly reduced ICU catheter complications in a multicenter randomized clinical trial.   Among 1,468 critically ill patients, EDTA locking solution lowered the composite risk of bloodstream infection, catheter occlusion requiring alteplase, and catheter removal due to occlusion. The strongest signal? Fewer catheter blockages and smoother ICU workflow. 💉🏥...

🌙🧠 Fascinating new insights from Science reveal that sleep is far more than "rest." During non-rapid eye movement sleep, neuromodulators synchronize into ~50-second oscillatory rhythms that coordinate vascular pulsations, cerebrospinal fluid flow, and glymphatic clearance of amyloid-β and tau.   This elegant systems-level biology may explain why aging, psychiatric disease, stress, cardiovascular...